Search

Your search keyword '"Jeffrey Anderson"' showing total 179 results

Search Constraints

Start Over You searched for: Author "Jeffrey Anderson" Remove constraint Author: "Jeffrey Anderson"
179 results on '"Jeffrey Anderson"'

Search Results

102. Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo: evidence for augmentation of a 42-specific γ secretase

103. Effects of ketamine and n-methyl-d-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268

104. Effects of Ibuprofen and Vicoprofen® on Physical Performance after Exercise-Induced Muscle Damage

105. Nivolumab dose escalation and expansion in patients with advanced hepatocellular carcinoma (HCC): The CheckMate 040 study

106. An Embryonic Journey of Musical Entrepreneurship with 'The Captain,' Jorma Kaukonen, and His Co-Pilot, Vanessa

107. ACCF/AHA/CDC Conference Report on Emerging Infectious Diseases and Biological Terrorism Threats

108. Blood Cultures Positive for Coagulase-Negative Staphylococci: Antisepsis, Pseudobacteremia, and Therapy of Patients

109. Book reviews

110. Factors associated with patient satisfaction scores for physician care in trauma patients

111. The Changing Roles of Faculty and Students when Mobile Devices Enter the Higher Education Classroom

112. Safety and preliminary efficacy of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (aHCC): Interim analysis of the phase 1/2 CheckMate-040 study

113. Phase I/II safety and antitumor activity of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (HCC): Interim analysis of the CheckMate-040 dose escalation study

114. A randomized, multicenter, phase 3 study of nivolumab vs sorafenib as first-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): CheckMate-459

115. Safety and antitumor activity of nivolumab (nivo) in patients (pts) with advanced hepatocellular carcinoma (HCC): Interim analysis of dose-expansion cohorts from the phase 1/2 CheckMate-040 study

116. Operations management and financial performance

117. Longitudinal Heschl's gyrus growth during childhood and adolescence in typical development and autism

118. <scp>J</scp> udson, <scp>A</scp> doniram (1788–1850)

119. <scp>F</scp> uller, <scp>A</scp> ndrew (1754–1815)

120. <scp>O</scp> wen, <scp>J</scp> ohn (1616–1683)

121. Chiral corrections to hyperon vector form factors

122. Regulation of the 18 kDa heat shock protein in Mycobacterium ulcerans: an alpha-crystallin orthologue that promotes biofilm formation

124. Teaching professionalism: a tale of three schools

125. Abstract 4603: Home Surveillance Results in Improved Interstage Weight Gain in Infants following the Norwood Operation

126. A mouse model of yellow fluorescent protein (YFP) expression in hematopoietic cells to assess leukocyte-endothelial interactions in the microcirculation

127. Xsketch: a multi-user sketching tool for X11

128. Cyclohexenyl- and dehydropiperidinyl-alkynyl pyridines as potent metabotropic glutamate subtype 5 (mGlu5) receptor antagonists

129. Atmospheric/Space Environment Support Lessons Learned Regarding Aerospace Vehicle Design and Operations

130. Hypothyroidism as a Risk Factor for Statin Intolerance*

131. Good and poor mobilizing patients differ in mobilized CD34+ cell adhesion molecule profiles

132. A Prospective Study of Overuse Knee Injuries Among Female Athletes With Muscle Imbalances and Structural Abnormalities

133. Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity

134. Service-Learning in Teacher Education: Accomplishments, Challenges, and Promising Developments

135. 3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity

136. Address medical decisions, return-to-play guidelines

137. Gambling as an addictive disorder among athletes: clinical issues in sports medicine

138. Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice

139. Continuity in trade and internal market

140. German Unification and the Union of Europe

141. Bibliography

142. A new Germany in Europe?

143. Mixed outcomes in energy and environment

145. Change in competition policy

147. Phase I dose escalation study of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) in patients (pts) with advanced hepatocellular carcinoma (HCC) with or without chronic viral hepatitis

148. Diagnostic utility and prognostic performance of a 92-gene cancer classifier to molecularly profile periampullary adenocarcinomas (PAA)

149. Group II selective MGLU receptor agonists block ketamine-evoked glutamate release in the rat prefrontal cortex and hippocampus

150. Factors Affecting Growth in Infants with Single Ventricle Physiology: A Report from the Pediatric Heart Network Infant Single Ventricle Trial

Catalog

Books, media, physical & digital resources